Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 18227347)

1.

The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target.

Hewamana S, Alghazal S, Lin TT, Clement M, Jenkins C, Guzman ML, Jordan CT, Neelakantan S, Crooks PA, Burnett AK, Pratt G, Fegan C, Rowntree C, Brennan P, Pepper C.

Blood. 2008 May 1;111(9):4681-9. doi: 10.1182/blood-2007-11-125278. Epub 2008 Jan 28.

2.
3.

NF-kappaB dimers in the regulation of neuronal survival.

Sarnico I, Lanzillotta A, Benarese M, Alghisi M, Baiguera C, Battistin L, Spano P, Pizzi M.

Int Rev Neurobiol. 2009;85:351-62. doi: 10.1016/S0074-7742(09)85024-1. Review.

PMID:
19607980
4.

NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia.

Pepper C, Hewamana S, Brennan P, Fegan C.

Future Oncol. 2009 Sep;5(7):1027-37. doi: 10.2217/fon.09.72. Review.

PMID:
19792971
5.

Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability.

Pizzi M, Sarnico I, Lanzillotta A, Battistin L, Spano P.

FEBS J. 2009 Jan;276(1):27-35. doi: 10.1111/j.1742-4658.2008.06767.x. Review.

PMID:
19087197
6.

NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.

Lanzillotta A, Porrini V, Bellucci A, Benarese M, Branca C, Parrella E, Spano PF, Pizzi M.

Front Neurol. 2015 May 20;6:98. doi: 10.3389/fneur.2015.00098. eCollection 2015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk